US2021332091A1PendingUtilityA1
Over-expression of gds1 in yeast for increased ethanol and decreased acetate production
Est. expirySep 28, 2038(~12.2 yrs left)· nominal 20-yr term from priority
C12P 7/54C12P 7/06C07K 14/395C12N 1/16C12N 9/16Y02E50/10
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described are compositions and methods relating to modified yeast that over-express the glycerol-deficient suppressor, GDS1. The yeast produces an increased amount of ethanol and a deceased amount of acetate compared to parental cells. Such yeast is particularly useful for large-scale ethanol production from starch substrates where acetate in an undesirable end product.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . Modified yeast cells derived from parental yeast cells, the modified cells comprising a genetic alteration that causes the modified cells to produce an increased amount of GDS1 polypeptides compared to the parental cells, wherein the modified cells produce during fermentation a decreased amount of acetate compared to the amount of acetate produced by the parental cells under identical fermentation conditions.
2 . The modified yeast cells of claim 1 , wherein the modified cells produce during fermentation an increased amount of ethanol compared to the amount of ethanol produced by the parental cells under identical fermentation conditions.
3 . The modified cells of claim 1 or 2 , wherein the genetic alteration comprises the introduction into the parental cells of a nucleic acid capable of directing the expression of a GDS1 polypeptide to a level above that of the parental cell grown under equivalent conditions.
4 . The modified cells of claim 1 or 2 , wherein the genetic alteration comprises the introduction of an expression cassette for expressing a GDS1 polypeptide.
5 . The modified cells of any of claims 1 - 5 , wherein the cells further comprising one or more genes of the phosphoketolase pathway.
6 . The modified cells of claim 5 , wherein the genes of the phosphoketolase pathway are selected from the group consisting of phosphoketolase, phosphotransacetylase and acetylating acetyl dehydrogenase.
7 . The modified cells of any of claims 1 - 6 , wherein the amount of increase in the expression of the GDS1 polypeptide is at least about 500% compared to the level expression in the parental cells grown under equivalent conditions.
8 . The modified cells of any of claims 1 - 6 , wherein the amount of increase in the production of mRNA encoding the GDS1 polypeptide is at least about 1000% compared to the level in the parental cells grown under equivalent conditions.
9 . The modified cells of any of claims 1 - 6 , wherein the amount of increase in the production of mRNA encoding the GDS1 polypeptide is at least about 5000% compared to the level in the parental cells grown under equivalent conditions.
10 . The modified cells of any of claims 1 - 6 , wherein the amount of increase in the production of mRNA encoding the GDS1 polypeptide is at least about 10000% compared to the level in the parental cells grown under equivalent conditions.
11 . The modified cells of any of claims 1 - 10 , wherein the cells further comprise an exogenous gene encoding a carbohydrate processing enzyme.
12 . The modified cells of any of claims 1 - 11 , further comprising an alteration in the glycerol pathway and/or the acetyl-CoA pathway.
13 . The modified cells of any of claims 1 - 12 , further comprising an alternative pathway for making ethanol.
14 . The modified cells of any of claims 1 - 13 , wherein the cells are of a Saccharomyces spp.
15 . A method for decreasing the production of acetate from yeast cells grown on a carbohydrate substrate, comprising: introducing into parental yeast cells a genetic alteration that increases the production of GDS1 polypeptides compared to the amount produced in the parental cells.
16 . A method for increasing the production of ethanol from yeast cells grown on a carbohydrate substrate, comprising: introducing into parental yeast cells a genetic alteration that increases the production of GDS1 polypeptides compared to the amount produced in the parental cells.
17 . The method of claim 15 or 16 , wherein the cells having the introduced genetic alteration are the modified cells are the cells of any of claims 1 - 15 .
18 . The method of claim 15 or 17 , wherein the decrease in acetate production is at least 10%, at least 15%, at least 20%, or at least 25%. or at least 30% compared to the amount produced in the parental cells.
19 . The method of claim 16 or 17 , wherein the increase in ethanol production is at least 0.1%, at least 0.2%, at least 0.3%, or at least 0.5%. or at least 1.0% compared to the amount produced in the parental cells.
20 . The method of any of claims 15 - 19 , wherein GDS1 polypeptides are over-expressed by at least 500%.
21 . The method of any of claims 15 - 19 , wherein GDS1 polypeptides are over-expressed by at least 5-fold.
22 . The method of any of claims 15 - 19 , wherein GDS1 polypeptides are over-expressed by at least 10-fold.
23 . The method of any of claims 15 - 19 , wherein GDS1 polypeptides are over-expressed by at least 50-fold.
24 . The method of any of claims 15 - 19 , wherein GDS1 polypeptides are over-expressed by at least 100-fold.Join the waitlist — get patent alerts
Track US2021332091A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.